BioAge Labs, Inc. (BIOA)
7.175
+0.12
(+1.77%)
USD |
NASDAQ |
Sep 28, 16:00
7.175
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Price : 7.175 for Sept. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 7.26 | 7.295 | 7.03 | 7.05 | 630289.0 |
| Sep 24, 2026 | 7.79 | 7.88 | 7.19 | 7.21 | 1.012M |
| Sep 23, 2026 | 8.43 | 8.49 | 7.68 | 7.89 | 618468.0 |
| Sep 22, 2026 | 8.20 | 8.53 | 8.11 | 8.46 | 1.067M |
| Sep 21, 2026 | 8.07 | 8.10 | 7.73 | 8.09 | 787316.0 |
| Sep 18, 2026 | 8.07 | 8.230 | 7.86 | 8.06 | 1.509M |
| Sep 17, 2026 | 7.85 | 8.36 | 7.70 | 8.09 | 940137.0 |
| Sep 16, 2026 | 8.21 | 8.275 | 7.62 | 7.75 | 715817.0 |
| Sep 15, 2026 | 8.48 | 8.50 | 8.02 | 8.18 | 643573.0 |
| Sep 14, 2026 | 8.52 | 8.635 | 8.39 | 8.48 | 563393.0 |
| Sep 11, 2026 | 8.71 | 8.89 | 8.28 | 8.49 | 672078.0 |
| Sep 10, 2026 | 9.07 | 9.07 | 8.60 | 8.65 | 492865.0 |
| Sep 09, 2026 | 9.38 | 9.40 | 9.02 | 9.17 | 488346.0 |
| Sep 08, 2026 | 9.60 | 9.645 | 9.324 | 9.395 | 388071.0 |
| Sep 04, 2026 | 9.39 | 9.76 | 9.39 | 9.59 | 314854.0 |
| Sep 03, 2026 | 9.90 | 9.98 | 9.415 | 9.50 | 407283.0 |
| Sep 02, 2026 | 9.59 | 10.05 | 9.425 | 9.73 | 541262.0 |
| Sep 01, 2026 | 9.28 | 9.72 | 9.150 | 9.52 | 605312.0 |
| Aug 31, 2026 | 9.61 | 9.63 | 9.20 | 9.50 | 1.033M |
| Aug 28, 2026 | 10.06 | 10.25 | 9.595 | 9.65 | 452194.0 |
| Aug 27, 2026 | 9.93 | 10.23 | 9.80 | 10.08 | 475429.0 |
| Aug 26, 2026 | 10.03 | 10.03 | 9.76 | 9.84 | 504282.0 |
| Aug 25, 2026 | 9.55 | 10.13 | 9.55 | 10.11 | 499332.0 |
| Aug 24, 2026 | 9.57 | 9.65 | 9.16 | 9.38 | 661583.0 |
| Aug 21, 2026 | 9.78 | 9.916 | 9.48 | 9.48 | 453445.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1185.55 |
| Pfizer Inc. | 28.74 |
| Oramed Pharmaceuticals, Inc. | 4.75 |
| Liquidia Corp. | 73.60 |
| Neumora Therapeutics, Inc. | 0.6918 |
Price Related Metrics
| PS Ratio | 27.59 |
| PEG Ratio | -0.4455 |
| Price to Book Value | 0.8761 |
| Earnings Yield | -33.27% |
| Market Cap | 328.45M |
| PEGY Ratio | -0.4455 |